Physician profile
Cory J Hess
NPI 1841518057
$803.28
in general payments reported to CMS, 2019-2025
10 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $96.95 · 2023: $24.02 · 2024: $196 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $280.73 | 2021-2025 | Spravato |
| Abbott Laboratories | $122.62 | 2024-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $119.70 | 2022-2024 | Linq II |
| Amgen INC. | $91.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $85.73 | 2024 | Eliquis, Camzyos |
| Smith+Nephew, INC. | $28.17 | 2025 | Grafix Pl |
| Inspire Medical Systems, INC. | $24.02 | 2023 | Inspire |
| Tactile Systems Technology INC | $20.77 | 2025 | Nimbl, Flexitouch Plus |
| Alnylam Pharmaceuticals INC. | $15.50 | 2025 | Amvuttra |
| Pfizer INC. | $14.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.